https://www.selleckchem.com/products/mdivi-1.html
23), VISTASEAL 1C (RR=2.00, 95% CrI 1.45-2.65), and TISSEEL 2C (RR=1.99, 95% CrI 1.48-2.6. TISSEEL 1C was not significantly different than manual compression (RR=1.40, 95% CrI 0.70-2.33). Among FSs, VISTASEAL 2C was associated with a significant improvements in T4 compared with VISTASEAL 1C (RR=1.33, 95% CrI 1.02-1.82), TISSEEL 2C (RR=1.34, 95% CrI 1.05-1.77), and TISSEEL 1C (RR=1.90, 95% CrI 1.18-3.74). Treatment-related serious and non-serious AE rates were typically lower than 2%. In peripheral vascular surgeries, VISTASEAL 2C and